Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Mark Gordon
CEO
mark@divinerinc.com

Message the company or request a 1:1 meeting here

Diviner uses collective human intelligence to predict clinical trial outcomes and their impact on biotech stocks. We will apply superior predictions of clinical trial success and stock price impact to biotech public equities investments focused on small/mid-cap, clinical-stage biotechs, and later to assess other types of drug development investments, such as in early-stage, private companies, and mid-cap commercial-stage biotechs launching products.